COVID-19 testing and patients in mental health facilities Benson, Nicole M et al. The Lancet Psychiatry, Volume 0, Issue 0 https://www.thelancet.com/journals/lancet/article/PIIS2215-0366(20)30198-X/fulltext

Addressing the public mental health challenge of COVID-19 Campion, Jonathan et al. The Lancet Psychiatry, Volume 0, Issue 0  https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30240-6/fulltext

Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2). Leppla IE, Gross MS. J Addict Med. 2020 May 14. doi: 10.1097/ADM.0000000000000678. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273937/

Does intranasal naloxone administration increase the risk of 2019 coronavirus disease transmission? Leong YC, Verbeek PR.  CJEM. 2020 May 12:1-2. doi: 10.1017/cem.2020.395. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251251/

Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report. Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL. J Addict Med. 2020 May 20. doi: 10.1097/ADM.0000000000000682. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC727394…

Studie: SARS-CoV-2 überlebt auf Oberflächen auch bei höheren Temperaturen Bochum – Das neue Coronavirus SARS-CoV-2 bleibt auf Oberflächen auch bei höheren Außentemperaturen über längere Zeit infektiös. Dies zeigen kürzlich im Journal of Infect…